SCHEMBL3772063

SCHEMBL3772063

CCCCCCCCCCCCCC=CC(O)C(COP(O)(O)=S)N(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SPHK2 Q9NRA0 4/20 0.62
▸ SPHK1 Q9NYA1 4/20 0.62
▸ CETP P11597 3/20 0.62
▸ PLA2G4A P47712 3/20 0.57
▸ LPAR3 Q9UBY5 5/20 0.51
▸ LPAR1 Q92633 3/20 0.51
▸ LPAR2 Q9HBW0 2/20 0.51
▸ S1PR4 O95977 2/20 0.51
▸ S1PR1 P21453 2/20 0.51
▸ S1PR3 Q99500 2/20 0.51
▸ S1PR5 Q9H228 2/20 0.51
▸ S1PR2 O95136 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ TSPO P30536 1/20 0.51
▸ TMEM97 Q5BJF2 1/20 0.51
▸ SIGMAR1 Q99720 1/20 0.51
▸ SGPL1 O95470 4/20 0.47
▸ BLM P54132 3/20 0.46
▸ ENPP2 Q13822 1/20 0.46
▸ RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22911020 0.87 PLA2G4A (0.73) SPHK2SPHK1CETPPLA2G4ALPAR3
SCHEMBL3768316 0.87 PLA2G4A (0.73) SPHK2SPHK1CETPPLA2G4ALPAR3
SCHEMBL3763587 0.81 S1PR1 (0.76) SPHK2SPHK1CETPPLA2G4ALPAR3
SCHEMBL3772519 0.79 LPAR3 (0.51) SPHK2SPHK1CETPPLA2G4ALPAR3
Dimethylspingosine SCHEMBL8258015 0.77 SPHK2 (1.00) SPHK2SPHK1CETPPLA2G4AALDH1A1
Dimethylspingosine SCHEMBL121926 0.77 SPHK2 (1.00) SPHK2SPHK1CETPPLA2G4AALDH1A1
Dimethylspingosine SCHEMBL121927 0.77 SPHK2 (1.00) SPHK2SPHK1CETPPLA2G4AALDH1A1
Dimethylspingosine SCHEMBL5493697 0.77 SPHK2 (1.00) SPHK2SPHK1CETPPLA2G4AALDH1A1
Dimethylspingosine SCHEMBL19745875 0.77 SPHK2 (0.86) SPHK2SPHK1CETPPLA2G4AS1PR4
SCHEMBL23925264 0.74 PLA2G4A (0.67) SPHK2SPHK1CETPPLA2G4ALPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190183910-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS OKTAY, KUTLUK (US) 2019-06-20 — — US claimed
US-5877167-A Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives OTSUKA AMERICA PHARMACEUTICAL, INC. (US) 1999-03-02 — — US claimed
EP-0671917-A4 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES. BIOMEMBRANE INST (US) 1997-06-18 — — EP claimed
EP-0671917-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES ONCOMEMBRANE, INC. (US) 1995-09-20 — — EP claimed
US-5260288-A Administering an inflammation inhibitory amount THE BIOMEMBRANE INSTITUTE (US) 1993-11-09 — — US claimed
WO-1993019760-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES THE BIOMEMBRANE INSTITUTE (US) 1993-10-14 — — WO claimed
WO-2021207858-A1 DIAGNOSIS AND TREATMENT OF COVID-19 LONDON HEALTH SCIENCES CENTRE RESEARCH INC. (CA) 2021-10-21 — — WO disclosed
US-20190183910-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS OKTAY, KUTLUK (US) 2019-06-20 — — US disclosed
WO-2017223152-A1 ENHANCING DNA REPAIR AND PREVENTING AGING AND ITS CONSEQUENCES IN REPRODUCTIVE AND OTHER CELLS NEW YORK MEDICAL COLLEGE (US) 2017-12-28 — — WO disclosed
US-7850984-B2 Protection of the female reproductive system from natural and artificial insults THE GENERAL HOSPITAL CORPORATION (US) 2010-12-14 — — US disclosed
US-20070157331-A1 Protection of female reproductive system from natural and artifical insults MASSACHUSETTS GENERAL HOSPITAL, PARTNERS HEALTHCARE RESEARCH VENTURES & LICENSING (US) 2007-07-05 — — US disclosed
US-7195775-B1 Protection of the female reproductive system from natural and artificial insults THE GENERAL HOSPITAL CORPORATION (US) 2007-03-27 — — US disclosed
US-20030157086-A1 Protection of the female reproductive system from natural and artificial insults SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2003-08-21 — — US disclosed
US-5877167-A Method for inhibition of cell motility by sphingosine-1-phosphate and its derivatives OTSUKA AMERICA PHARMACEUTICAL, INC. (US) 1999-03-02 — — US disclosed
US-5663404-A ANTITUMOR AGENTS; ANTIINFLAMMATORY AGENTS ONCOMEMBRANE (US) 1997-09-02 — — US disclosed
EP-0671917-A4 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES. BIOMEMBRANE INST (US) 1997-06-18 — — EP disclosed
EP-0671917-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES ONCOMEMBRANE, INC. (US) 1995-09-20 — — EP disclosed
US-5391800-A Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer THE BIOMEMBRANE INSTITUTE (US) 1995-02-21 — — US disclosed
US-5260288-A Administering an inflammation inhibitory amount THE BIOMEMBRANE INSTITUTE (US) 1993-11-09 — — US disclosed
WO-1993019760-A1 METHOD FOR INHIBITION OF CELL MOTILITY BY SPHINGOSINE-1-PHOSPHATE, ITS DERIVATIVES AND MIMETICS AND METHOD OF SYNTHESIZING SPHINGOSINE-1-PHOSPHATE AND ITS DERIVATIVES THE BIOMEMBRANE INSTITUTE (US) 1993-10-14 — — WO disclosed
Send feedback